LivaNova (LIVN) Total Debt (2015 - 2026)
LivaNova (LIVN) reported Total Debt of $287.9 million for Q1 2026, down 59.32% on a YoY basis from $707.7 million in Q1 2025, and down 32.44% sequentially from $426.1 million in Q4 2025.
LivaNova (LIVN) Total Debt (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Total Debt data on file, last reported at $287.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 59.32% year-over-year to $287.9 million; the trailing twelve-month figure through Mar 2026 stood at $287.9 million (down 59.32% YoY), and the FY2025 full-year result was $426.1 million, down 39.56% from the prior year.
- Total Debt slipped to $287.9 million in Q1 2026, from $426.1 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $707.7 million in Q1 2025 to a low of $287.9 million in Q1 2026.
- A 5-year average of $544.5 million and a median of $564.1 million in 2023 frame the typical range for Total Debt.
- Across the five-year window, Total Debt grew 29.92% in 2023 and sank 59.32% in 2026, its largest moves.
- Tracing LIVN's Total Debt over 5 years: stood at $541.5 million in 2022, then advanced by 11.56% to $604.1 million in 2023, then advanced by 16.7% to $705.0 million in 2024, then tumbled by 39.56% to $426.1 million in 2025, then slumped by 32.44% to $287.9 million in 2026.
- Business Quant data shows LIVN's Total Debt at $287.9 million in Q1 2026, $426.1 million in Q4 2025, and $434.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.48 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.14 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 287.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 287.91 Mn |
| Dec 31, 2025 | 426.13 Mn |
| Sep 30, 2025 | 434.47 Mn |
| Jun 30, 2025 | 430.62 Mn |
| Mar 31, 2025 | 707.72 Mn |
| Dec 31, 2024 | 705.00 Mn |
| Sep 30, 2024 | 626.24 Mn |
| Jun 30, 2024 | 625.17 Mn |
| Mar 31, 2024 | 624.46 Mn |
| Dec 31, 2023 | 604.11 Mn |
| Sep 30, 2023 | 587.19 Mn |
| Jun 30, 2023 | 605.47 Mn |
| Mar 31, 2023 | 564.06 Mn |
| Dec 31, 2022 | 541.50 Mn |
| Sep 30, 2022 | 558.69 Mn |
| Jun 30, 2022 | 466.03 Mn |
| Mar 31, 2022 | 462.29 Mn |
| Dec 31, 2021 | 466.47 Mn |
| Sep 30, 2021 | 462.18 Mn |
| Jun 30, 2021 | 663.05 Mn |